UniProt ID | NU107_HUMAN | |
---|---|---|
UniProt AC | P57740 | |
Protein Name | Nuclear pore complex protein Nup107 | |
Gene Name | NUP107 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 925 | |
Subcellular Localization | Nucleus membrane . Nucleus, nuclear pore complex . Chromosome, centromere, kinetochore . Located on both the cytoplasmic and nuclear sides of the NPC core structure (PubMed:11564755). During mitosis, localizes to the kinetochores (PubMed:11564755). D | |
Protein Description | Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. [PubMed: 12552102] | |
Protein Sequence | MDRSGFGEISSPVIREAEVTRTARKQSAQKRVLLQASQDENFGNTTPRNQVIPRTPSSFRQPFTPTSRSLLRQPDISCILGTGGKSPRLTQSSGFFGNLSMVTNLDDSNWAAAFSSQRSGLFTNTEPHSITEDVTISAVMLREDDPGEAASMSMFSDFLQSFLKHSSSTVFDLVEEYENICGSQVNILSKIVSRATPGLQKFSKTASMLWLLQQEMVTWRLLASLYRDRIQSALEEESVFAVTAVNASEKTVVEALFQRDSLVRQSQLVVDWLESIAKDEIGEFSDNIEFYAKSVYWENTLHTLKQRQLTSYVGSVRPLVTELDPDAPIRQKMPLDDLDREDEVRLLKYLFTLIRAGMTEEAQRLCKRCGQAWRAATLEGWKLYHDPNVNGGTELEPVEGNPYRRIWKISCWRMAEDELFNRYERAIYAALSGNLKQLLPVCDTWEDTVWAYFRVMVDSLVEQEIQTSVATLDETEELPREYLGANWTLEKVFEELQATDKKRVLEENQEHYHIVQKFLILGDIDGLMDEFSKWLSKSRNNLPGHLLRFMTHLILFFRTLGLQTKEEVSIEVLKTYIQLLIREKHTNLIAFYTCHLPQDLAVAQYALFLESVTEFEQRHHCLELAKEADLDVATITKTVVENIRKKDNGEFSHHDLAPALDTGTTEEDRLKIDVIDWLVFDPAQRAEALKQGNAIMRKFLASKKHEAAKEVFVKIPQDSIAEIYNQCEEQGMESPLPAEDDNAIREHLCIRAYLEAHETFNEWFKHMNSVPQKPALIPQPTFTEKVAHEHKEKKYEMDFGIWKGHLDALTADVKEKMYNVLLFVDGGWMVDVREDAKEDHERTHQMVLLRKLCLPMLCFLLHTILHSTGQYQECLQLADMVSSERHKLYLVFSKEELRKLLQKLRESSLMLLDQGLDPLGYEIQL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MDRSGFGE -------CCCCCCCC | 9.73 | 20068231 | |
4 | Phosphorylation | ----MDRSGFGEISS ----CCCCCCCCCCC | 33.92 | 30266825 | |
10 | Phosphorylation | RSGFGEISSPVIREA CCCCCCCCCHHHHHH | 25.04 | 29255136 | |
11 | Phosphorylation | SGFGEISSPVIREAE CCCCCCCCHHHHHHH | 28.93 | 19664994 | |
20 | Phosphorylation | VIREAEVTRTARKQS HHHHHHHHHHHHHHH | 17.51 | 21949786 | |
22 | Phosphorylation | REAEVTRTARKQSAQ HHHHHHHHHHHHHHH | 22.81 | 23879269 | |
25 | Methylation | EVTRTARKQSAQKRV HHHHHHHHHHHHHHH | 46.25 | 116252445 | |
37 | Phosphorylation | KRVLLQASQDENFGN HHHHHHHHCCCCCCC | 25.79 | 29255136 | |
45 | Phosphorylation | QDENFGNTTPRNQVI CCCCCCCCCCCCCCC | 38.26 | 23401153 | |
46 | Phosphorylation | DENFGNTTPRNQVIP CCCCCCCCCCCCCCC | 25.01 | 29255136 | |
50 | Ubiquitination | GNTTPRNQVIPRTPS CCCCCCCCCCCCCCC | 35.48 | 21890473 | |
55 | Phosphorylation | RNQVIPRTPSSFRQP CCCCCCCCCCCCCCC | 23.36 | 27273156 | |
56 | Ubiquitination | NQVIPRTPSSFRQPF CCCCCCCCCCCCCCC | 29.29 | 32015554 | |
56 | Ubiquitination | NQVIPRTPSSFRQPF CCCCCCCCCCCCCCC | 29.29 | - | |
57 | Phosphorylation | QVIPRTPSSFRQPFT CCCCCCCCCCCCCCC | 41.31 | 23401153 | |
58 | Phosphorylation | VIPRTPSSFRQPFTP CCCCCCCCCCCCCCC | 26.17 | 23401153 | |
60 | Asymmetric dimethylarginine | PRTPSSFRQPFTPTS CCCCCCCCCCCCCCH | 45.25 | - | |
60 | Methylation | PRTPSSFRQPFTPTS CCCCCCCCCCCCCCH | 45.25 | 24129315 | |
64 | Phosphorylation | SSFRQPFTPTSRSLL CCCCCCCCCCHHHHH | 32.13 | 27273156 | |
64 | O-linked_Glycosylation | SSFRQPFTPTSRSLL CCCCCCCCCCHHHHH | 32.13 | 30059200 | |
66 | Phosphorylation | FRQPFTPTSRSLLRQ CCCCCCCCHHHHHCC | 33.44 | 30266825 | |
67 | Phosphorylation | RQPFTPTSRSLLRQP CCCCCCCHHHHHCCC | 22.52 | 21712546 | |
67 | O-linked_Glycosylation | RQPFTPTSRSLLRQP CCCCCCCHHHHHCCC | 22.52 | 30059200 | |
68 | Methylation | QPFTPTSRSLLRQPD CCCCCCHHHHHCCCC | 33.53 | 58858727 | |
69 | Phosphorylation | PFTPTSRSLLRQPDI CCCCCHHHHHCCCCE | 31.36 | 23927012 | |
77 | Phosphorylation | LLRQPDISCILGTGG HHCCCCEEEEECCCC | 11.50 | 23401153 | |
82 | Phosphorylation | DISCILGTGGKSPRL CEEEEECCCCCCCCC | 39.04 | 29255136 | |
85 | Ubiquitination | CILGTGGKSPRLTQS EEECCCCCCCCCCCC | 59.64 | 33845483 | |
85 | Acetylation | CILGTGGKSPRLTQS EEECCCCCCCCCCCC | 59.64 | 25953088 | |
86 | Phosphorylation | ILGTGGKSPRLTQSS EECCCCCCCCCCCCC | 20.66 | 29255136 | |
103 | Phosphorylation | FGNLSMVTNLDDSNW CCCEEEEECCCCCCH | 22.79 | 27732954 | |
108 | Phosphorylation | MVTNLDDSNWAAAFS EEECCCCCCHHHHHH | 33.66 | 27732954 | |
115 | Phosphorylation | SNWAAAFSSQRSGLF CCHHHHHHHCCCCCC | 22.34 | 26074081 | |
116 | Phosphorylation | NWAAAFSSQRSGLFT CHHHHHHHCCCCCCC | 24.14 | 26074081 | |
119 | Phosphorylation | AAFSSQRSGLFTNTE HHHHHCCCCCCCCCC | 32.01 | 26074081 | |
123 | Phosphorylation | SQRSGLFTNTEPHSI HCCCCCCCCCCCCCC | 46.39 | 26074081 | |
125 | Phosphorylation | RSGLFTNTEPHSITE CCCCCCCCCCCCCCC | 48.08 | 26074081 | |
129 | Phosphorylation | FTNTEPHSITEDVTI CCCCCCCCCCCCCEE | 41.75 | 26074081 | |
131 | Phosphorylation | NTEPHSITEDVTISA CCCCCCCCCCCEEEE | 29.19 | 26074081 | |
135 | Phosphorylation | HSITEDVTISAVMLR CCCCCCCEEEEEEEC | 22.87 | 27732954 | |
137 | Phosphorylation | ITEDVTISAVMLRED CCCCCEEEEEEECCC | 12.87 | 27732954 | |
153 | Phosphorylation | PGEAASMSMFSDFLQ CCHHHHHHHHHHHHH | 17.74 | 20068231 | |
156 | Phosphorylation | AASMSMFSDFLQSFL HHHHHHHHHHHHHHH | 20.86 | 20068231 | |
161 | Phosphorylation | MFSDFLQSFLKHSSS HHHHHHHHHHHCCCC | 34.39 | 24719451 | |
172 | Ubiquitination | HSSSTVFDLVEEYEN CCCCCHHHHHHHHHH | 45.53 | 27667366 | |
172 | Ubiquitination | HSSSTVFDLVEEYEN CCCCCHHHHHHHHHH | 45.53 | - | |
175 | Ubiquitination | STVFDLVEEYENICG CCHHHHHHHHHHHCH | 63.26 | 22817900 | |
193 | Phosphorylation | NILSKIVSRATPGLQ HHHHHHHHHCCCCHH | 21.48 | 29514088 | |
196 | Phosphorylation | SKIVSRATPGLQKFS HHHHHHCCCCHHHHH | 19.44 | 29514088 | |
201 | Ubiquitination | RATPGLQKFSKTASM HCCCCHHHHHHHHHH | 57.56 | 21906983 | |
201 | Ubiquitination | RATPGLQKFSKTASM HCCCCHHHHHHHHHH | 57.56 | 21890473 | |
204 | Ubiquitination | PGLQKFSKTASMLWL CCHHHHHHHHHHHHH | 51.77 | 22817900 | |
232 | Phosphorylation | LYRDRIQSALEEESV HHHHHHHHHHHHCCC | 32.23 | - | |
251 | Phosphorylation | AVNASEKTVVEALFQ ECCCCHHHHHHHHHC | 26.23 | 28555341 | |
261 | Phosphorylation | EALFQRDSLVRQSQL HHHHCCCHHHHHHHH | 30.84 | 20860994 | |
276 | Ubiquitination | VVDWLESIAKDEIGE HHHHHHHHHCCHHCC | 3.94 | 21963094 | |
276 | Ubiquitination | VVDWLESIAKDEIGE HHHHHHHHHCCHHCC | 3.94 | - | |
296 | Phosphorylation | EFYAKSVYWENTLHT HHHEEEHHHHCHHHH | 17.69 | 28796482 | |
303 | Ubiquitination | YWENTLHTLKQRQLT HHHCHHHHHHHHHHH | 38.47 | 29967540 | |
303 | Ubiquitination | YWENTLHTLKQRQLT HHHCHHHHHHHHHHH | 38.47 | - | |
305 | Methylation | ENTLHTLKQRQLTSY HCHHHHHHHHHHHHH | 44.59 | 42360801 | |
305 | Ubiquitination | ENTLHTLKQRQLTSY HCHHHHHHHHHHHHH | 44.59 | 21906983 | |
305 | 2-Hydroxyisobutyrylation | ENTLHTLKQRQLTSY HCHHHHHHHHHHHHH | 44.59 | - | |
315 | Phosphorylation | QLTSYVGSVRPLVTE HHHHHHCCCCHHEEC | 12.62 | - | |
321 | Phosphorylation | GSVRPLVTELDPDAP CCCCHHEECCCCCCC | 38.21 | - | |
332 | Ubiquitination | PDAPIRQKMPLDDLD CCCCCCCCCCHHHCC | 32.41 | 21906983 | |
333 | Sulfoxidation | DAPIRQKMPLDDLDR CCCCCCCCCHHHCCH | 2.77 | 21406390 | |
348 | Ubiquitination | EDEVRLLKYLFTLIR HHHHHHHHHHHHHHH | 44.49 | - | |
349 | Phosphorylation | DEVRLLKYLFTLIRA HHHHHHHHHHHHHHC | 13.66 | 28188228 | |
352 | Phosphorylation | RLLKYLFTLIRAGMT HHHHHHHHHHHCCCC | 20.76 | 28188228 | |
353 | Ubiquitination | LLKYLFTLIRAGMTE HHHHHHHHHHCCCCH | 1.63 | 21963094 | |
353 | Ubiquitination | LLKYLFTLIRAGMTE HHHHHHHHHHCCCCH | 1.63 | - | |
359 | Phosphorylation | TLIRAGMTEEAQRLC HHHHCCCCHHHHHHH | 29.74 | 28188228 | |
379 | Ubiquitination | AWRAATLEGWKLYHD HHHHHCCCCCCCCCC | 59.67 | 22505724 | |
379 | Ubiquitination | AWRAATLEGWKLYHD HHHHHCCCCCCCCCC | 59.67 | - | |
382 | Ubiquitination | AATLEGWKLYHDPNV HHCCCCCCCCCCCCC | 50.45 | 21906983 | |
408 | Ubiquitination | NPYRRIWKISCWRMA CCCCEEEEEEEHHHH | 23.52 | 22505724 | |
408 | Acetylation | NPYRRIWKISCWRMA CCCCEEEEEEEHHHH | 23.52 | 26051181 | |
428 | Phosphorylation | NRYERAIYAALSGNL HHHHHHHHHHHCCCH | 5.71 | 28152594 | |
432 | Phosphorylation | RAIYAALSGNLKQLL HHHHHHHCCCHHHHH | 22.40 | 28152594 | |
462 | Ubiquitination | VMVDSLVEQEIQTSV HHHHHHHHHHHHHCC | 48.03 | 29967540 | |
462 | Ubiquitination | VMVDSLVEQEIQTSV HHHHHHHHHHHHHCC | 48.03 | - | |
472 | Ubiquitination | IQTSVATLDETEELP HHHCCCCCCCCCCCC | 3.95 | 22817900 | |
472 | Ubiquitination | IQTSVATLDETEELP HHHCCCCCCCCCCCC | 3.95 | - | |
473 | Ubiquitination | QTSVATLDETEELPR HHCCCCCCCCCCCCH | 57.31 | 22817900 | |
473 | Ubiquitination | QTSVATLDETEELPR HHCCCCCCCCCCCCH | 57.31 | - | |
475 | Phosphorylation | SVATLDETEELPREY CCCCCCCCCCCCHHH | 34.13 | 20860994 | |
481 | Ubiquitination | ETEELPREYLGANWT CCCCCCHHHHCCCCH | 43.07 | 22817900 | |
482 | Ubiquitination | TEELPREYLGANWTL CCCCCHHHHCCCCHH | 16.24 | 22817900 | |
482 | Phosphorylation | TEELPREYLGANWTL CCCCCHHHHCCCCHH | 16.24 | 21406692 | |
488 | Phosphorylation | EYLGANWTLEKVFEE HHHCCCCHHHHHHHH | 25.50 | 21406692 | |
491 | Ubiquitination | GANWTLEKVFEELQA CCCCHHHHHHHHHHC | 56.17 | 29967540 | |
501 | Ubiquitination | EELQATDKKRVLEEN HHHHCCCHHHHHHHH | 37.82 | 21906983 | |
502 | Ubiquitination | ELQATDKKRVLEENQ HHHCCCHHHHHHHHH | 51.02 | 22817900 | |
512 | Phosphorylation | LEENQEHYHIVQKFL HHHHHHHHHHHHHHH | 7.78 | - | |
534 | Ubiquitination | LMDEFSKWLSKSRNN HHHHHHHHHHHHCCC | 12.50 | 21890473 | |
569 | Phosphorylation | LQTKEEVSIEVLKTY CCCCCCHHHHHHHHH | 19.13 | 20068231 | |
597 | Ubiquitination | AFYTCHLPQDLAVAQ EEEEECCCHHHHHHH | 11.28 | 21963094 | |
597 | Ubiquitination | AFYTCHLPQDLAVAQ EEEEECCCHHHHHHH | 11.28 | - | |
606 | Ubiquitination | DLAVAQYALFLESVT HHHHHHHHHHHHHHC | 4.63 | 21963094 | |
608 | Ubiquitination | AVAQYALFLESVTEF HHHHHHHHHHHHCHH | 5.60 | 21963094 | |
608 | Ubiquitination | AVAQYALFLESVTEF HHHHHHHHHHHHCHH | 5.60 | - | |
616 | Ubiquitination | LESVTEFEQRHHCLE HHHHCHHHHHHHHHH | 40.24 | - | |
617 | Ubiquitination | ESVTEFEQRHHCLEL HHHCHHHHHHHHHHH | 56.16 | 21963094 | |
626 | Ubiquitination | HHCLELAKEADLDVA HHHHHHHHHCCCCHH | 67.09 | 21963094 | |
637 | Ubiquitination | LDVATITKTVVENIR CCHHEEEHHHHHHHH | 35.16 | 21906983 | |
642 | Ubiquitination | ITKTVVENIRKKDNG EEHHHHHHHHHHCCC | 27.96 | 33845483 | |
645 | Ubiquitination | TVVENIRKKDNGEFS HHHHHHHHHCCCCCC | 61.76 | - | |
646 | Ubiquitination | VVENIRKKDNGEFSH HHHHHHHHCCCCCCC | 46.72 | 29967540 | |
652 | Phosphorylation | KKDNGEFSHHDLAPA HHCCCCCCCCCCCCC | 18.66 | 23898821 | |
655 | Ubiquitination | NGEFSHHDLAPALDT CCCCCCCCCCCCCCC | 38.82 | 21890473 | |
661 | Ubiquitination | HDLAPALDTGTTEED CCCCCCCCCCCCHHH | 45.24 | 27667366 | |
661 | Ubiquitination | HDLAPALDTGTTEED CCCCCCCCCCCCHHH | 45.24 | - | |
670 | Ubiquitination | GTTEEDRLKIDVIDW CCCHHHHHCEEEEEE | 9.85 | 27667366 | |
671 | Ubiquitination | TTEEDRLKIDVIDWL CCHHHHHCEEEEEEE | 37.44 | 33845483 | |
674 | Ubiquitination | EDRLKIDVIDWLVFD HHHHCEEEEEEEECC | 4.95 | 27667366 | |
675 | Ubiquitination | DRLKIDVIDWLVFDP HHHCEEEEEEEECCH | 2.52 | 22817900 | |
680 | Ubiquitination | DVIDWLVFDPAQRAE EEEEEEECCHHHHHH | 9.73 | 22817900 | |
680 | Ubiquitination | DVIDWLVFDPAQRAE EEEEEEECCHHHHHH | 9.73 | - | |
683 | Ubiquitination | DWLVFDPAQRAEALK EEEECCHHHHHHHHH | 17.21 | 27667366 | |
684 | Ubiquitination | WLVFDPAQRAEALKQ EEECCHHHHHHHHHH | 50.97 | 22817900 | |
685 | Ubiquitination | LVFDPAQRAEALKQG EECCHHHHHHHHHHC | 36.18 | 21963094 | |
685 | Ubiquitination | LVFDPAQRAEALKQG EECCHHHHHHHHHHC | 36.18 | - | |
689 | Ubiquitination | PAQRAEALKQGNAIM HHHHHHHHHHCHHHH | 2.99 | 22817900 | |
690 | Ubiquitination | AQRAEALKQGNAIMR HHHHHHHHHCHHHHH | 64.31 | 21906983 | |
694 | Ubiquitination | EALKQGNAIMRKFLA HHHHHCHHHHHHHHH | 12.09 | 21963094 | |
702 | Phosphorylation | IMRKFLASKKHEAAK HHHHHHHHCCHHHHH | 44.37 | 22964224 | |
703 | Ubiquitination | MRKFLASKKHEAAKE HHHHHHHCCHHHHHH | 53.17 | 27667366 | |
704 | Ubiquitination | RKFLASKKHEAAKEV HHHHHHCCHHHHHHH | 44.15 | 22817900 | |
709 | Acetylation | SKKHEAAKEVFVKIP HCCHHHHHHHEEECC | 62.55 | 24889073 | |
709 | Ubiquitination | SKKHEAAKEVFVKIP HCCHHHHHHHEEECC | 62.55 | 21906983 | |
714 | Acetylation | AAKEVFVKIPQDSIA HHHHHEEECCHHHHH | 36.89 | 24889081 | |
714 | Ubiquitination | AAKEVFVKIPQDSIA HHHHHEEECCHHHHH | 36.89 | 21963094 | |
724 | Phosphorylation | QDSIAEIYNQCEEQG HHHHHHHHHHHHHCC | 7.23 | 26714015 | |
734 | Phosphorylation | CEEQGMESPLPAEDD HHHCCCCCCCCCCCC | 23.89 | 26714015 | |
744 | Ubiquitination | PAEDDNAIREHLCIR CCCCCHHHHHHHHHH | 7.14 | 33845483 | |
744 | Ubiquitination | PAEDDNAIREHLCIR CCCCCHHHHHHHHHH | 7.14 | - | |
753 | Ubiquitination | EHLCIRAYLEAHETF HHHHHHHHHHHHHHH | 8.67 | 21890473 | |
756 | Ubiquitination | CIRAYLEAHETFNEW HHHHHHHHHHHHHHH | 11.83 | 33845483 | |
756 | Ubiquitination | CIRAYLEAHETFNEW HHHHHHHHHHHHHHH | 11.83 | - | |
773 | Ubiquitination | HMNSVPQKPALIPQP HHCCCCCCCCCCCCC | 26.62 | 22817900 | |
773 | Ubiquitination | HMNSVPQKPALIPQP HHCCCCCCCCCCCCC | 26.62 | 21890473 | |
774 | Ubiquitination | MNSVPQKPALIPQPT HCCCCCCCCCCCCCC | 27.35 | 29967540 | |
781 | Phosphorylation | PALIPQPTFTEKVAH CCCCCCCCCCHHHHH | 37.63 | 28555341 | |
785 | Ubiquitination | PQPTFTEKVAHEHKE CCCCCCHHHHHHHHH | 41.48 | 21963094 | |
785 | Ubiquitination | PQPTFTEKVAHEHKE CCCCCCHHHHHHHHH | 41.48 | - | |
787 | Ubiquitination | PTFTEKVAHEHKEKK CCCCHHHHHHHHHHC | 17.26 | 22817900 | |
794 | Ubiquitination | AHEHKEKKYEMDFGI HHHHHHHCEEECCCC | 47.75 | 21963094 | |
796 | Ubiquitination | EHKEKKYEMDFGIWK HHHHHCEEECCCCHH | 40.95 | 22817900 | |
803 | Ubiquitination | EMDFGIWKGHLDALT EECCCCHHHHHHHHC | 34.23 | 29967540 | |
808 | Ubiquitination | IWKGHLDALTADVKE CHHHHHHHHCHHHHH | 17.11 | 33845483 | |
814 | Ubiquitination | DALTADVKEKMYNVL HHHCHHHHHHHCCEE | 52.76 | 21963094 | |
814 | 2-Hydroxyisobutyrylation | DALTADVKEKMYNVL HHHCHHHHHHHCCEE | 52.76 | - | |
816 | Ubiquitination | LTADVKEKMYNVLLF HCHHHHHHHCCEEEE | 40.75 | 22817900 | |
837 | Ubiquitination | VDVREDAKEDHERTH EECCHHHHHHHHHHH | 75.81 | 33845483 | |
858 | Ubiquitination | KLCLPMLCFLLHTIL HHHHHHHHHHHHHHH | 1.51 | 33845483 | |
865 | Ubiquitination | CFLLHTILHSTGQYQ HHHHHHHHHHCCCHH | 2.47 | 21890473 | |
865 | Ubiquitination | CFLLHTILHSTGQYQ HHHHHHHHHHCCCHH | 2.47 | - | |
874 | Ubiquitination | STGQYQECLQLADMV HCCCHHHHHHHHHHH | 1.41 | 21890473 | |
887 | Ubiquitination | MVSSERHKLYLVFSK HHCCCCCCEEEEECH | 45.08 | 33845483 | |
893 | O-linked_Glycosylation | HKLYLVFSKEELRKL CCEEEEECHHHHHHH | 31.51 | 30059200 | |
894 | Ubiquitination | KLYLVFSKEELRKLL CEEEEECHHHHHHHH | 43.68 | 21890473 | |
894 | Ubiquitination | KLYLVFSKEELRKLL CEEEEECHHHHHHHH | 43.68 | 21890473 | |
907 | Phosphorylation | LLQKLRESSLMLLDQ HHHHHHHHHHHHHHC | 23.49 | 30387612 | |
908 | Phosphorylation | LQKLRESSLMLLDQG HHHHHHHHHHHHHCC | 17.03 | 30387612 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NU107_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NU107_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NU107_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-10 AND SER-11, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-37 AND THR-46,AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-10 AND SER-11, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-11; SER-37;THR-46; THR-55; SER-58; THR-64; SER-69; SER-77 AND SER-86, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11 AND THR-55, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-11; THR-46;THR-55; SER-58 AND THR-64, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-46, AND MASSSPECTROMETRY. |